Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lojuxta 10mg capsules
0212000AFBBABAB
|
Lojuxta | Lomitapide | Cardiovascular System | No data available |
|
Lojuxta 20mg capsules
0212000AFBBACAC
|
Lojuxta | Lomitapide | Cardiovascular System | No data available |
|
Lojuxta 5mg capsules
0212000AFBBAAAA
|
Lojuxta | Lomitapide | Cardiovascular System | No data available |
|
Lomitapide 10mg capsules
0212000AFAAABAB
|
Lomitapide | Lomitapide | Cardiovascular System | No data available |
|
Lomitapide 20mg capsules
0212000AFAAACAC
|
Lomitapide | Lomitapide | Cardiovascular System | No data available |
|
Lomitapide 5mg capsules
0212000AFAAAAAA
|
Lomitapide | Lomitapide | Cardiovascular System | No data available |
|
Lomont 70mg/5ml oral suspension
0403010R0BCAAAL
|
Lomont | Lofepramine hydrochloride | Central Nervous System | No data available |
|
Lomotil 2.5mg/25microgram tablets (Advanz Phamra)
0104020H0BBAAAA
|
Lomotil | Co-phenotrope (Diphenox hydrochloride/atropine sulfate) | Gastro-Intestinal System | No data available |
|
Lomustine 100mg capsules
0801010Q0AAADAD
|
Lomustine | Lomustine | Malignant Disease and Immunosuppression | No data available |
|
Lomustine 10mg capsules
0801010Q0AAAAAA
|
Lomustine | Lomustine | Malignant Disease and Immunosuppression | No data available |
|
Lomustine 40mg capsules
0801010Q0AAABAB
|
Lomustine | Lomustine | Malignant Disease and Immunosuppression | No data available |
|
Long flanged plastic bag compatible with MK5, MK6, MK8, MK10, MK12 urinal system 32/38mm
22903409033
|
Long flanged plastic bag compatible with MK5, MK6, MK8, MK10, MK12 urinal system 32/38mm | Urinal Systems | Incontinence Appliances | No data available |
|
Long flanged plastic bag compatible with MK5, MK6, MK8, MK10, MK12 urinal system 45mm
22903409034
|
Long flanged plastic bag compatible with MK5, MK6, MK8, MK10, MK12 urinal system 45mm | Urinal Systems | Incontinence Appliances | No data available |
|
Long flanged plastic bag with foam pad, compatible with MK4 urinal system 32/38mm
22903409032
|
Long flanged plastic bag with foam pad, compatible with MK4 urinal system 32/38mm | Urinal Systems | Incontinence Appliances | No data available |
|
Long flanged plastic bag with foam pad, compatible with MK4 urinal system 45mm
22903409122
|
Long flanged plastic bag with foam pad, compatible with MK4 urinal system 45mm | Urinal Systems | Incontinence Appliances | No data available |
|
Lonquex 6mg/0.6ml solution for injection pre-filled syringes
0901060Q0BBAAAA
|
Lonquex | Lipegfilgrastim | Nutrition and Blood | No data available |
|
Lonsurf 15mg/6.14mg tablets
0801030AFBBAAAA
|
Lonsurf | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Lonsurf 20mg/8.19mg tablets
0801030AFBBABAB
|
Lonsurf | Trifluridine/tipiracil | Malignant Disease and Immunosuppression | No data available |
|
Lopace 10mg capsules
0205051R0BCACAD
|
Lopace | Ramipril | Cardiovascular System | No data available |
|
Lopace 2.5mg capsules
0205051R0BCAAAB
|
Lopace | Ramipril | Cardiovascular System | No data available |
|
Lopace 5mg capsules
0205051R0BCABAC
|
Lopace | Ramipril | Cardiovascular System | No data available |
|
Loperamide 15mg/5ml oral solution
0104020L0AAASAS
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Loperamide 2.5mg/5ml oral liquid
0104020L0AAAKAK
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Loperamide 4mg/5ml oral liquid
0104020L0AAAHAH
|
Loperamide hydrochloride | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Lopinavir 100mg / Ritonavir 25mg tablets
0503010G0AAADAD
|
Lopinavir/ritonavir | Lopinavir and ritonavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.